The enhanced NK-mediated tumor lysis promoted by tuvusertib was not only due to immunogenic modulation on tumor cells but was also associated with increased perforin and granzyme B expression on the N-803-stimulated NK cell population when co-cultured with tuvusertib-treated cells (Fig. 6B). Here, PRF1 is linked to neoplasm.